News

GFCI

Delcath Systems (DCTH) Nearly Doubles on FDA Orphan Status Announcement

Joel Anderson | Equities.com |

Shares in Delcath Systems (DCTH) nearly doubled Wednesday after the FDA announced that it had granted orphan status to melphalan for treatment of patients with hepatocellular carcinoma (primary



Discover: Trending Events

United Nations
Blockchain for Europe
Humanity 2.0
World Economic Forum